Tanshinone IIA Inhibits NADPH Oxidase 4 Expression by Regulating Sestrin2-Mediated AMPK/mTOR Signaling Pathway to

Congying Guo1,2, Sheng Ai1,2, Mingyu Wu1,2

  • 1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China.

Insights

Tanshinone IIA (Tan-IIA) combats pulmonary fibrosis by inhibiting NADPH oxidase 4 (Nox4) and reducing oxidative stress. It achieves this by upregulating Sestrin2 (Sesn2), which activates AMPK and inhibits mTOR, thereby preventing myofibroblast activation.

Area of Science:

  • Cell Biology
  • Molecular Medicine
  • Pharmacology

Background:

  • Pulmonary fibrosis (PF) is driven by oxidative stress and myofibroblast activation.
  • NADPH oxidase 4 (Nox4) is a key source of reactive oxygen species (ROS) in PF and a therapeutic target.
  • Tanshinone IIA (Tan-IIA) from Salvia miltiorrhiza shows potential in ameliorating PF by inhibiting Nox4.

Purpose of the Study:

  • To investigate Tan-IIA's protective effects against myofibroblast activation in PF.
  • To elucidate the upstream molecular mechanisms by which Tan-IIA regulates Nox4.
  • To determine the role of Sestrin2 (Sesn2) in Tan-IIA's mechanism of action.

Main Methods:

  • Utilized a mouse model of bleomycin-induced PF.
  • Employed in vitro models of transforming growth factor beta 1 (TGF-β1)-stimulated myofibroblast activation.
  • Analyzed the expression of Nox4, Sestrin2 (Sesn2), AMP-activated protein kinase (AMPK), and mammalian target of rapamycin (mTOR).

Main Results:

  • Tan-IIA inhibited myofibroblast activation and reduced extracellular matrix deposition in vivo.
  • Tan-IIA upregulated Sesn2 and suppressed Nox4 expression in both in vitro and in vivo models.
  • Sesn2 mediated Tan-IIA's antifibrotic effects by inhibiting Nox4-induced oxidative stress.
  • Tan-IIA activated AMPK and inhibited mTOR through Sesn2 upregulation.

Conclusions:

  • Tan-IIA suppresses Nox4-mediated oxidative stress and myofibroblast activation in PF.
  • The Sesn2/AMPK/mTOR signaling pathway is crucial for Tan-IIA's therapeutic effects.
  • Tan-IIA represents a promising therapeutic agent for pulmonary fibrosis by targeting the Sesn2/Nox4 axis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K